Portfolio company
ClexBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops bioengineered vascular tissues and microfluidic hydrogel technology for researchers and clinical partners to treat chronic organ diseases and liver failure.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Satellite Bio
This company develops implantable bioengineered tissues to repair and restore organ function for patients with severe diseases including liver failure.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Ochre-Bio
This company develops RNA-based therapies and human liver data sets for pharmaceutical businesses to treat chronic liver diseases.
VISCIENT
This company develops novel therapies and drug discovery platforms using three-dimensional human tissue models to treat liver diseases for biopharmaceutical partners.
ReproGo
This regenerative medicine company develops stem cell-derived vascular cells and organoids for drug screening and treating chronic wounds and cardiovascular diseases.
Cellbricks
Cellbricks develops 3D-bioprinted human tissue implants and vascularised therapeutics for patients with complex wounds, soft tissue defects and organ damage.
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
Cellink
This company develops 3D bioprinters and bioinks for researchers in academic, pharmaceutical and industrial laboratories to create human tissue models and organs.
